# Pilot Study of Bisphosphonates for Breast Cancer

> **NCT02781805** · PHASE1 · TERMINATED · sponsor: **University of Wisconsin, Madison** · enrollment: 6 (actual)

## Conditions studied

- Breast Neoplasms

## Interventions

- **DRUG:** Alendronate

## Key facts

- **NCT ID:** NCT02781805
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-08-05
- **Primary completion:** 2018-12-12
- **Final completion:** 2018-12-12
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2020-10-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02781805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02781805, "Pilot Study of Bisphosphonates for Breast Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02781805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*